These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 24328376)
21. An Integrated Metabolomic and Microbiome Analysis Identified Specific Gut Microbiota Associated with Fecal Cholesterol and Coprostanol in Clostridium difficile Infection. Antharam VC; McEwen DC; Garrett TJ; Dossey AT; Li EC; Kozlov AN; Mesbah Z; Wang GP PLoS One; 2016; 11(2):e0148824. PubMed ID: 26871580 [TBL] [Abstract][Full Text] [Related]
22. Lyn deficiency leads to increased microbiota-dependent intestinal inflammation and susceptibility to enteric pathogens. Roberts ME; Bishop JL; Fan X; Beer JL; Kum WW; Krebs DL; Huang M; Gill N; Priatel JJ; Finlay BB; Harder KW J Immunol; 2014 Nov; 193(10):5249-63. PubMed ID: 25339668 [TBL] [Abstract][Full Text] [Related]
23. [Antibiotic-associated diarrhea]. Reisinger EC; Lademann M; Krause R Dtsch Med Wochenschr; 2004 Sep; 129 Suppl 2():S111-3. PubMed ID: 15368187 [No Abstract] [Full Text] [Related]
24. Role of bacterial metabolism and physiology in the pathogenesis of Clostridium difficile disease. Bongaerts GP; Lyerly DM Microb Pathog; 1997 Apr; 22(4):253-6. PubMed ID: 9140922 [No Abstract] [Full Text] [Related]
25. Chloride-led disruption of the intestinal mucous layer impedes Salmonella invasion: evidence for an 'enteric tear' mechanism. Keely S; Feighery L; Campion DP; O'Brien L; Brayden DJ; Baird AW Cell Physiol Biochem; 2011; 28(4):743-52. PubMed ID: 22178886 [TBL] [Abstract][Full Text] [Related]
26. Interleukin-22-mediated host glycosylation prevents Clostridioides difficile infection by modulating the metabolic activity of the gut microbiota. Nagao-Kitamoto H; Leslie JL; Kitamoto S; Jin C; Thomsson KA; Gillilland MG; Kuffa P; Goto Y; Jenq RR; Ishii C; Hirayama A; Seekatz AM; Martens EC; Eaton KA; Kao JY; Fukuda S; Higgins PDR; Karlsson NG; Young VB; Kamada N Nat Med; 2020 Apr; 26(4):608-617. PubMed ID: 32066975 [TBL] [Abstract][Full Text] [Related]
27. The microbiota mediates pathogen clearance from the gut lumen after non-typhoidal Salmonella diarrhea. Endt K; Stecher B; Chaffron S; Slack E; Tchitchek N; Benecke A; Van Maele L; Sirard JC; Mueller AJ; Heikenwalder M; Macpherson AJ; Strugnell R; von Mering C; Hardt WD PLoS Pathog; 2010 Sep; 6(9):e1001097. PubMed ID: 20844578 [TBL] [Abstract][Full Text] [Related]
28. Recurrent Clostridium difficile infections: the importance of the intestinal microbiota. Zanella Terrier MC; Simonet ML; Bichard P; Frossard JL World J Gastroenterol; 2014 Jun; 20(23):7416-23. PubMed ID: 24966611 [TBL] [Abstract][Full Text] [Related]
29. Effect of antibiotic therapy on human fecal microbiota and the relation to the development of Clostridium difficile. De La Cochetière MF; Durand T; Lalande V; Petit JC; Potel G; Beaugerie L Microb Ecol; 2008 Oct; 56(3):395-402. PubMed ID: 18209965 [TBL] [Abstract][Full Text] [Related]
30. Updating changes in human gut microbial communities associated with Herrera G; Paredes-Sabja D; Patarroyo MA; Ramírez JD; Muñoz M Gut Microbes; 2021; 13(1):1966277. PubMed ID: 34486488 [No Abstract] [Full Text] [Related]
31. Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection. Theriot CM; Koenigsknecht MJ; Carlson PE; Hatton GE; Nelson AM; Li B; Huffnagle GB; Z Li J; Young VB Nat Commun; 2014; 5():3114. PubMed ID: 24445449 [TBL] [Abstract][Full Text] [Related]